Zhongguo Dongmai Yinghua Zazhi (ZDYZ)

Zhongguo Dongmai Yinghua Zazhi (Chinese Journal of Arteriosclerosis) is a peer-reviewed medical journal published by the Editorial Office of the Chinese Journal of Arteriosclerosis in China. The journal focuses on research related to arteriosclerosis, cardiovascular medicine, vascular biology, and associated clinical and experimental studies. It serves as a platform for physicians, researchers, and healthcare professionals to publish original research articles, reviews, case reports, and clinical studies related to cardiovascular and arterial diseases. The journal emphasizes advancements in the prevention, diagnosis, and treatment of arteriosclerosis and related chronic cardiovascular conditions. It supports scientific exchange in areas such as lipid metabolism disorders, vascular inflammation, atherosclerotic plaque formation, and cardiovascular risk factors. Since becoming open access in 2021, the journal has increased its global visibility and allows wider dissemination of research findings under a CC BY-NC-ND license. It follows a double-blind peer review process and maintains academic standards through editorial and plagiarism checks. The journal primarily publishes content in Chinese, with structured abstracts available for broader accessibility. It plays an important role in China’s cardiovascular research community and contributes to ongoing clinical and biomedical advancements in arteriosclerosis management and prevention.

Zhongguo Dongmai Yinghua Zazhi (ZDYZ) is :-

• International, Peer-Reviewed, Open Access, Refereed, Cardiovascular Medicine, Arteriosclerosis & Vascular Diseases, lipid metabolism disorders, vascular inflammation, atherosclerotic plaque formation, cardiovascular risk factors, reviews, case reports, clinical studies related to cardiovascular and arterial diseases , Online , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN E-ISSN: 1007-3949, Established: 2019,
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE